$223.61
0.78% day before yesterday
Nasdaq, Nov 01, 09:00 pm CET
ISIN
US12572Q1058
Symbol
CME

CME Group a Target price 2024 - Analyst rating & recommendation

CME Group a Classifications & Recommendation:

Buy
40%
Hold
45%
Sell
15%

CME Group a Price Target

Target Price $237.81
Price $223.61
Potential
Number of Estimates 16
16 Analysts have issued a price target CME Group a 2025 . The average CME Group a target price is $237.81. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 20 analysts: 8 Analysts recommend CME Group a to buy, 9 to hold and 3 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the CME Group a stock has an average upside potential 2025 of . Most analysts recommend the CME Group a stock at Hold.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion $ 5.58 6.12
11.15% 9.77%
EBITDA Margin 67.90% 70.30%
0.88% 3.53%

15 Analysts have issued a sales forecast CME Group a 2024 . The average CME Group a sales estimate is

$6.1b
Unlock
. This is
1.32% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$6.2b 2.62%
Unlock
, the lowest is
$6.0b 0.02%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $5.6b 11.15%
2024
$6.1b 9.77%
Unlock
2025
$6.3b 2.52%
Unlock
2026
$6.6b 4.54%
Unlock
2027
$6.9b 5.61%
Unlock
2028
$7.3b 5.50%
Unlock

10 Analysts have issued an CME Group a EBITDA forecast 2024. The average CME Group a EBITDA estimate is

$4.3b
Unlock
. This is
2.81% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$4.4b 4.51%
Unlock
, the lowest is
$4.2b 1.01%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $3.8b 12.13%
2024
$4.3b 13.64%
Unlock
2025
$4.4b 3.00%
Unlock
2026
$4.7b 4.99%
Unlock
2027
$5.0b 7.28%
Unlock
2028
$5.2b 3.13%
Unlock

EBITDA Margin

2023 67.90% 0.88%
2024
70.30% 3.53%
Unlock
2025
70.63% 0.47%
Unlock
2026
70.93% 0.42%
Unlock
2027
72.05% 1.58%
Unlock
2028
70.44% 2.23%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ 8.86 9.82
19.73% 10.84%
P/E 22.76
EV/Sales 13.31

7 Analysts have issued a CME Group a forecast for earnings per share. The average CME Group a <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$9.82
Unlock
. This is
3.26% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$10.35 8.83%
Unlock
, the lowest is
$9.59 0.84%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $8.86 19.73%
2024
$9.82 10.84%
Unlock
2025
$10.02 2.04%
Unlock
2026
$10.43 4.09%
Unlock
2027
$11.06 6.04%
Unlock
2028
$11.41 3.16%
Unlock

P/E ratio

Current 23.52 5.73%
2024
22.76 3.23%
Unlock
2025
22.32 1.93%
Unlock
2026
21.43 3.99%
Unlock
2027
20.23 5.60%
Unlock
2028
19.60 3.11%
Unlock

Based on analysts' sales estimates for 2024, the CME Group a stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

13.31
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
13.15
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 13.49 5.93%
2024
13.31 1.34%
Unlock
2025
12.98 2.45%
Unlock
2026
12.42 4.34%
Unlock
2027
11.76 5.32%
Unlock
2028
11.15 5.21%
Unlock

P/S ratio

Current 13.32 5.26%
2024
13.15 1.31%
Unlock
2025
12.83 2.45%
Unlock
2026
12.27 4.34%
Unlock
2027
11.62 5.32%
Unlock
2028
11.01 5.21%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today